Eyüp Sabri Ercan Selected Research

Atomoxetine Hydrochloride (Strattera)

2/2021

Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eyüp Sabri Ercan Research Topics

Disease

5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 01/2003
2	Conduct Disorder (Conduct Disorders) 02/2018 - 01/2003
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 07/2022
1	Sluggish Cognitive Tempo 02/2021
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Anorexia Nervosa 07/2003
1	Oppositional Defiant Disorder 01/2003
1	Body Weight (Weight, Body) 01/2003

Drug/Important Bio-Agent (IBA)

4	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022 - 01/2017
2	Risperidone (Risperdal Consta)FDA LinkGeneric 02/2018 - 01/2003
1	Aripiprazole (Abilify)FDA Link 07/2022
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 02/2021
1	EnzymesIBA 01/2017
1	Olanzapine (Zyprexa)FDA Link 07/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 02/2021
1	Treatment Delay 12/2020